Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Protein farnesyltransferase | Starlite/ChEMBL | References |
Homo sapiens | Harvey rat sarcoma viral oncogene homolog | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | ras-related protein Rab-18 | Harvey rat sarcoma viral oncogene homolog | 189 aa | 177 aa | 25.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0069 | 0.7974 | 1 |
Plasmodium vivax | farnesyltransferase beta subunit, putative | 0.0067 | 0.7363 | 1 |
Trypanosoma cruzi | lanosterol synthase, putative | 0.0074 | 1 | 1 |
Schistosoma mansoni | protein farnesyltransferase subunit beta | 0.0067 | 0.7363 | 0.5 |
Trichomonas vaginalis | dexras1, putative | 0.0069 | 0.7974 | 1 |
Echinococcus granulosus | ras gtpase | 0.0069 | 0.7974 | 1 |
Trichomonas vaginalis | rheb, putative | 0.0069 | 0.7974 | 1 |
Entamoeba histolytica | Ras family GTPase | 0.0069 | 0.7974 | 1 |
Echinococcus multilocularis | ras gtpase | 0.0069 | 0.7974 | 1 |
Trypanosoma brucei | lanosterol synthase | 0.0074 | 1 | 1 |
Giardia lamblia | Prenyltransferase | 0.0067 | 0.7363 | 0.5 |
Brugia malayi | Ras-related protein R-Ras2 | 0.0069 | 0.7974 | 1 |
Trichomonas vaginalis | GTP-binding protein rit, putative | 0.0069 | 0.7974 | 1 |
Loa Loa (eye worm) | Ras protein let-60 | 0.0069 | 0.7974 | 1 |
Brugia malayi | Ras protein let-60 | 0.0069 | 0.7974 | 1 |
Trichomonas vaginalis | ras-dva small GTPase, putative | 0.0069 | 0.7974 | 1 |
Leishmania major | farnesyltransferase beta subunit | 0.0067 | 0.7363 | 1 |
Entamoeba histolytica | ras-1, putative | 0.0069 | 0.7974 | 1 |
Entamoeba histolytica | Ras family GTPase | 0.0069 | 0.7974 | 1 |
Toxoplasma gondii | prenyltransferase and squalene oxidase repeat-containing protein | 0.0067 | 0.7363 | 0.5 |
Trypanosoma cruzi | lanosterol synthase, putative | 0.0074 | 1 | 1 |
Trichomonas vaginalis | ral, putative | 0.0069 | 0.7974 | 1 |
Trichomonas vaginalis | rap1 and, putative | 0.0069 | 0.7974 | 1 |
Plasmodium falciparum | protein farnesyltransferase subunit beta | 0.0067 | 0.7363 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.006 uM | In vitro inhibition of rat farnesyltransferase. | ChEMBL. | 9341905 |
IC50 (binding) | = 0.006 uM | In vitro inhibition of rat farnesyltransferase. | ChEMBL. | 9341905 |
IC50 (functional) | = 0.088 uM | Concentration required to inhibit 50% of the cultured colonies of H-Ras-Fcells . | ChEMBL. | 9341905 |
IC50 (functional) | = 0.088 uM | Concentration required to inhibit 50% of the cultured colonies of H-Ras-Fcells . | ChEMBL. | 9341905 |
MED (functional) | = 0.02 uM | Minimum effective dose required to detect unfarnesylated Ras in H-Ras-transformed NIH3T3 (H-Ras-F) cells injected into mice. | ChEMBL. | 9341905 |
MED (functional) | = 0.02 uM | Minimum effective dose required to detect unfarnesylated Ras in H-Ras-transformed NIH3T3 (H-Ras-F) cells injected into mice. | ChEMBL. | 9341905 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.